Brevan Howard Capital Management 13F: Adds $4.6M to ALB Stake

Brevan Howard Expands Exposure to Specialty Chemicals

Brevan Howard Capital Management increased its investment in Albemarle Corporation NYSE:ALB during the period, according to a Form 13F filed with the U.S. Securities and Exchange Commission. The macro-focused fund has been actively shifting its portfolio across sectors, recently scaling back some holdings while boosting others like its position in The Cheesecake Factory and establishing new stakes in companies such as Allegro MicroSystems.

Position Growth in Albemarle Shares

The fund added 34,234 shares of Albemarle Corporation, marking a 148.3% increase from its previous holding of 23,084 shares. This brought Brevan Howard's total stake to 57,318 shares, with an estimated reported value of roughly $7.68 million based on the filing period. Because 13F filings look backward to past quarters, this snapshot reflects holdings at that specific moment and may not show the fund's current trading activity.

Albemarle Stock Context and Market Levels

Shares of Albemarle trade around $133.94, navigating a 52-week range that spans from a low of $79.30 up to a high of $221.00. The company carries a trailing price-to-earnings ratio of 418.2 while trading on a forward P/E of roughly 10.0. Its 50-day moving average sits at $125.08, while the 200-day moving average rests higher at $156.26.

Analysts Set New Price Targets

Financial institutions have frequently adjusted their outlooks on the specialty chemicals producer in recent months. On October 15, 2026, RBC Capital kept an outperform rating on the stock while moving its target to $129.00 from $157.00. Earlier in the month, Mizuho maintained a neutral stance with a $130.00 target on October 1, 2026, and later offered an outperform rating on October 14, 2026. Barclays initiated coverage on October 13, 2026, with an equal-weight rating and a $109.00 target, while Argus Research kept a buy rating and a $135.00 target on October 7, 2026. UBS maintained a buy rating with a $150.00 target on October 5, 2026.

Inside Albemarle Corporation's Operations

Headquartered in Charlotte, North Carolina, Albemarle Corporation operates as a major provider of energy storage solutions, specialty chemicals, and catalyst technologies. The firm supplies lithium compounds essential for electric vehicles and power grids, alongside bromine and clean fuel technologies for various industrial applications.

Looking Ahead After the Filing

Investors tracking Brevan Howard's portfolio adjustments will look to subsequent regulatory disclosures to see how the firm manages its energy storage exposure. Albemarle itself prepares for its next quarterly financial update scheduled for November 4, 2026, which will provide fresh data on revenue and earnings performance.